INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025)
INVO Fertility's (IVF) quarterly Preferred Stock Liabilities came in at $4.0 million in Q1 2025, down 46.64% on a QoQ basis from $7.5 million in Q4 2024.
INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends
INVO Fertility (IVF) has 2 years of Preferred Stock Liabilities data on file, last reported at $4.0 million in Q1 2025.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $4.0 million in Q1 2025; TTM through Mar 2025 was $4.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $7.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2025 stood at $4.0 million, down from $7.5 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for IVF reached as high as $7.5 million in Q4 2024 and fell as low as $4.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 7.46 Mn |